FindTrial
Sign In

clinical study to predict outcome in patients with brain haemorrhage

Serum MMP-9 as a predictor of delayed cerebral ischaemia in patients with aneurysmal subarachnoid haemorrhage.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/07/044238
Enrollment
98
Registered
2022-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G94- Other disorders of brain in diseases classified elsewhere

Interventions

None listed

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients presenting within 4 days of aneurysmal subarachnoid haemorrhage and planned for either surgical clipping or endovascular coiling

Exclusion criteria

Exclusion criteria: pre-existing vasospasm pre-existing neurological deficits refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
development of delayed cerebral ischaemiaTimepoint: daily—

Secondary

MeasureTime frame
GOSETimepoint: 3 months;mRS scoreTimepoint: at discharge, 3months—

Countries

India

Contacts

Public ContactVinitha

Post graduate institute of medical education and research

hembhagat@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026